Family Factors in Young People With Diabetes: a Qualitative Study
NCT ID: NCT04322071
Last Updated: 2020-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
16 participants
OBSERVATIONAL
2020-02-26
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes Intervention Program for Adolescents With Persistent High HA1c
NCT02212158
Parents of Young Adults With Type 1 Diabetes: An Exploratory Study
NCT03158415
Improving Self-Efficacy, Quality of Life and Glycemic Control in Adolescents With Type 1 Diabetes
NCT06694467
Self Efficacy Levels, Attachment Style and Resiliency of Youth With Type 1 Diabetes
NCT04172077
Children and Adolescent Registry for Diabetes Study in Jiangxi
NCT03399565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During this qualitative study the researcher will meet with young people (aged 12-15yrs) and their families for a joint interview, held in the family home, exploring the factors which they consider important in diabetes self-management.
One interview will be held with each family. Recruitment of 8 families is planned.
The interviews will be recorded and transcribed to allow thematic analysis, allowing identification of common factors considered to be important by families.
The HbA1c of young people with diabetes is checked regularly in clinic and provides an assessment of blood glucose levels over the preceding months. Higher HbA1c levels are associated with higher risk of long term complications.
The index young people will be recruited in 2 groups: one group will have lower risk of long term complications (identified by an HbA1c level of \<58mmol/mol). The other will have higher risk (HbA1c 75-100mmol/mol). A comparison will be made between the families in each group, to identify which themes are more common in the lower or higher risk groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lower risk of long term complications
Young people with diabetes who have HbA1c \<58mmols/mol, and family members.
Interview
Qualitative interviews only
Higher risk of long term complications
Young people with diabetes who have HbA1c ≥75mmols/mol and \<100mmols/mol, and family members.
Interview
Qualitative interviews only
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interview
Qualitative interviews only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 1 diabetes diagnosed for at least 6 months
* Group 1: HbA1c \<58mmols/mol on last known test
* Group 2: HbA1c ≥75mmols/mol and \<100mmols/mol on last known test
* Willing to participate in group interview with at least one parent/carer
Exclusion Criteria
* Participants with inadequate English to take part in a semi-structured interview conducted in English
* Children and Young people for whom the last HbA1c incongruent with their previous results will be excluded
12 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
East Kent Hospitals University NHS Foundation Trust
OTHER_GOV
University of Southampton
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anitha Kumaran, MBBS, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Southampton
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
East Kent Hospitals University Foundation NHS Trust
Ashford, Kent, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
52030
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.